Author: admin

Chronic Wounds Market Gains Momentum with Expanding Pipeline and Investment Potential by 2034 – DelveInsight

DelveInsight’s “Chronic Wounds Market Insights, Epidemiology, and Market Forecast-2034” report offers an in-depth understanding of Chronic Wounds, historical and forecasted epidemiology as well as the Chronic Wounds market trends in the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom and Japan.

Some of the key facts of the Chronic Wounds Market Report:

  • The Chronic Wounds market size across the 7MM was valued at approximately USD 9,000 million in 2023.

  • The Chronic Wounds market in the United States was valued at approximately USD 6,000 million in 2023.

  • In 2023, the 7MM accounted for approximately 12 million diagnosed prevalent cases of Chronic Wounds.

  • The prevalent cases of Chronic Wounds by type are segmented into Pressure Ulcers, Diabetic Foot Ulcers, Venous Ulcers, and other types. In the US, Pressure Ulcers accounted for 38% of cases, Diabetic Foot Ulcers for 35%, Venous Ulcers for 18%, and other types for 9%.

  • Key Chronic Wounds Companies: Biotissue, PolarityTE, RHEACELL GmbH & Co. KG, Smith & Nephew, Kaken Pharmaceutical, MediWound, Paracrine, Inc., Oneness Biotech, Anterogen Co., Ltd., TR Therapeutics, and others.

  • Key Chronic Wounds Therapies: Regranex (becaplermin), Fiblast (trafermin), ON101, TTAX01, revyve® Antimicrobial Wound Cleanser, and others.

  • The Chronic Wounds market is expected to surge due to the disease’s increasing prevalence and aging population during the forecast period. Furthermore, launching various multiple-stage Chronic Wounds pipeline products will significantly revolutionize the Chronic Wounds market dynamics.

Chronic Wounds Overview

Chronic wounds are defined as wounds with an inability to heal within an anticipated time frame. They are widespread and frequently mistreated. A wound is considered chronic or non-healing when it has not fully healed even after four to six weeks of screening. Venous ulcers (VU), diabetic foot ulcers (DFU), and pressure ulcers (PU) are examples of common chronic wound types. Chronic wounds are influenced by factors such as underlying health conditions, wound location, the presence of infection, and individual genetic factors.

Get a Free sample for the Chronic Wounds Market Forecast, Size & Share Analysis Report

Chronic Wounds Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Chronic Wounds Epidemiology Segmentation:

The Chronic Wounds market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:

  • Total Prevalent Cases of Chronic Wounds

  • Total Diagnosed Prevalent Cases of Chronic Wounds

  • Type-specific Cases of Chronic Wounds

  • Total Prevalence of Chronic Wounds by Geographic Region

  • Total Prevalence of Chronic Wounds by Underlying Etiology

Download the report to understand which factors are driving Chronic Wounds epidemiology trends @ Chronic Wounds Epidemiology Forecast

Chronic Wounds Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Chronic Wounds market or expected to get launched during the study period. The analysis covers Chronic Wounds market uptake by drugs, patient uptake by therapies, and sales of each drug.

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Chronic Wounds Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Chronic Wounds Therapies and Key Companies

  • Regranex (becaplermin): Smith & Nephew

  • Fiblast (trafermin): Kaken Pharmaceutical

  • ON101: Oneness Biotech

  • TTAX01: Biotissue

  • revyve® Antimicrobial Wound Cleanser: Kane Biotech Inc.

Discover more about therapies set to grab major Chronic Wounds market share @ Chronic Wounds Treatment Landscape

Chronic Wounds Market Drivers

  • Rising Prevalence of Chronic Diseases: Increasing cases of diabetes, obesity, and vascular disorders contribute to a higher incidence of chronic wounds, boosting market demand.

  • Aging Population: Growth in the elderly population, who are more prone to wounds such as pressure ulcers and diabetic foot ulcers, drives market expansion.

  • Advancements in Wound Care Products: Introduction of advanced dressings, bioengineered skin substitutes, and negative pressure wound therapy stimulates adoption.

  • Rising Awareness and Early Diagnosis: Enhanced patient education, physician awareness, and early intervention strategies improve treatment uptake.

  • Healthcare Infrastructure and Reimbursement Policies: Better healthcare access and supportive insurance coverage encourage timely treatment, further expanding market growth.

Chronic Wounds Market Barriers

  • Scarcity of epidemiology data, resulting in a limited understanding of disease prevalence and limiting healthcare planning.

  • Lack of reliable biomarkers for wound healing, restricting the ability to accurately predict healing trajectories.

  • High treatment and care costs, which may limit access and reimbursement in certain regions.

  • Complexity and variability of wound healing processes among different patients, making it difficult to predict and manage healing trajectory effectively.

Scope of the Chronic Wounds Market Report

  • Coverage: 7MM

  • Study Period: 2020-2034

  • Forecast Period: 2024-2034

  • Key Chronic Wounds Companies: Biotissue, PolarityTE, RHEACELL GmbH & Co. KG, Smith & Nephew, Kaken Pharmaceutical, MediWound, Paracrine, Inc., Oneness Biotech, Anterogen Co., Ltd., TR Therapeutics, and others

  • Key Chronic Wounds Therapies: Regranex (becaplermin), Fiblast (trafermin), ON101, TTAX01, and others

  • Chronic Wounds Therapeutic Assessment: Chronic Wounds current marketed and Chronic Wounds emerging therapies

  • Chronic Wounds Market Dynamics: Chronic Wounds market drivers and Chronic Wounds market barriers

  • Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies

  • Chronic Wounds Unmet Needs, KOL’s views, Analyst’s views, Chronic Wounds Market Access and Reimbursement

To Know in detail about the Chronic Wounds market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Chronic Wounds Market Forecast

Table of Contents

  1. Key Insights

  2. Report Introduction

  3. Chronic Wounds Market Overview at a Glance

  4. Chronic Wounds Market: Future Perspective

  5. Executive Summary of Chronic Wounds

  6. Key Events

  7. Disease Background and Overview

  8. Epidemiology and Patient Population

  9. Patient Journey

  10. Marketed Drugs

  11. Emerging Drugs

  12. Chronic Wounds: Market Analysis

  13. KOL Views

  14. SWOT Analysis

  15. Unmet Needs

  16. Market Access and Reimbursement

  17. Appendix

  18. DelveInsight Capabilities

  19. Disclaimer

  20. About DelveInsight

About DelveInsight

DelveInsight is a leading Healthcare Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kanishk Kumar
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: https://www.delveinsight.com/
Country: United States
Website: https://www.delveinsight.com/

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Chronic Wounds Market Gains Momentum with Expanding Pipeline and Investment Potential by 2034 – DelveInsight

Primary Sclerosing Cholangitis Market is Projected to Boom by 2034 Owing to the Launch of Novel Therapies | DelveInsight

The Primary Sclerosing Cholangitis market is set for growth, driven by rising diagnosed cases, greater disease awareness, and advancing therapies. Companies such as Pliant Therapeutics, Inc. and HighTide Therapeutics are developing promising candidates, including bexotegrast (PLN-74809) and HTD1801, which could significantly improve future treatment options.

DelveInsight, a leading market research firm, announces the release of its latest report, “DelveInsight’s Primary Sclerosing Cholangitis Market Insights, Epidemiology, and Market Forecast 2034”. This comprehensive report provides an in-depth understanding of Primary Sclerosing Cholangitis, including historical and forecasted epidemiology, market trends, and treatment scenarios across the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom, and Japan.

 

Discover Key Insights into the Primary Sclerosing Cholangitis Market with DelveInsight’s In-Depth Report @ Primary Sclerosing Cholangitis Market Size

Key Takeaways from the Primary Sclerosing Cholangitis Market

  • The market size for Primary Sclerosing Cholangitis in the leading markets is expected to grow USD 80 million by 2034.

  • The United States accounted for the highest Primary Sclerosing Cholangitis treatment market size in 7MM in 2024, in comparison to the other major markets, i.e., EU4 countries, the United Kingdom, and Japan.

  • The US recorded the highest diagnosed Primary Sclerosing Cholangitis prevalence in 2023, with approximately 31 thousand cases, and is expected to grow further.

  • Among European countries, Germany had the highest prevalence (~5 thousand cases), followed by the UK, while Spain reported the lowest prevalence (~0.1 thousand cases).

  • Japan accounted for around 3 thousand diagnosed prevalent cases in 2023, representing nearly 5% of the total 7MM burden.

  • In the US, males accounted for the majority of diagnosed cases (~21 thousand) compared to females (~10 thousand) in 2023.

  • In Japan, 62% of diagnosed cases were asymptomatic, while 38% were symptomatic in 2023.

  • Inflammatory Bowel Disease (IBD) remains the leading comorbidity, with approximately 23 thousand associated cases in the US in 2023, a figure expected to increase over the forecast period.

  • Leading Primary Sclerosing Cholangitis companies developing emerging therapies, such as Gilead Sciences, Phenex Pharmaceuticals, HighTide Therapeutics, Dr. Falk Pharma, Mirum Pharmaceuticals, Pliant Therapeutics, Inc, NGM Biopharmaceuticals, CymaBay Therapeutics, Chemomab Therapeutics, and others, are developing new therapy for Primary Sclerosing Cholangitis that can be available in the Primary Sclerosing Cholangitis market in the coming years.

  • The promising Primary Sclerosing Cholangitis therapies in clinical trials include HTD 1801, PLN-74809 (bexotegrast), and others.

Keen to know more about the market? Request our sample page @ Primary Sclerosing Cholangitis Market Report

Key Factors Driving the Primary Sclerosing Cholangitis Market

Primary Sclerosing Cholangitis Market Drivers

  • Rising diagnosed prevalence of Primary Sclerosing Cholangitis across major markets.

  • Growing awareness and improvements in early disease diagnosis.

  • Strong pipeline development with emerging therapies such as bexotegrast and HTD1801.

  • Increased R&D investments and clinical trial activity by leading pharmaceutical companies.

Primary Sclerosing Cholangitis Market Landscape

  • Primary Sclerosing Cholangitis treatment primarily focuses on symptom management and slowing disease progression through ursodeoxycholic acid, endoscopic interventions, immunosuppressants, antibiotics, and antipruritic therapies. Liver transplantation remains the only curative option for advanced disease. With current treatments offering limited long-term benefits, emerging therapies such as HTD1801 hold promise for addressing significant unmet medical needs.

Primary Sclerosing Cholangitis Competitive Landscape

  • HTD 1801: HighTide Biopharma

HTD1801 is a first-in-class oral therapeutic composed of two active components, berberine and ursodeoxycholic acid, combined as a novel ionic salt. The drug functions as a lipid modulator and has demonstrated the ability to significantly reduce liver fat accumulation. HTD1801 has completed a Phase II clinical trial in Primary Sclerosing Cholangitis (PSC) and continues to be evaluated in Phase II studies for additional chronic diseases. It has been granted both Orphan Drug Designation (ODD) and Fast Track Designation (FTD). In June 2021, HighTide Therapeutics presented topline results from its PSC study of HTD1801 at the International Liver Congress 2021.

  • PLN-74809 (bexotegrast): Pliant Therapeutics, Inc.

PLN-74809 (Bexotegrast) is an oral dual-selective αvβ6/αvβ1 integrin inhibitor being developed for Primary Sclerosing Cholangitis (PSC). By blocking integrin-mediated activation of TGF-β, a key driver of fibrosis, the therapy aims to slow or prevent scar tissue formation in affected bile ducts. In July 2022, Pliant Therapeutics received FDA Fast Track Designation (FTD) for PLN-74809 in PSC.

Recent Developments in the Primary Sclerosing Cholangitis Market

  • In May 2026, Ipsen announced result of A Phase III, Multicentre, Randomised, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Elafibranor in Adult Participants With Primary Sclerosing Cholangitis

What is Primary Sclerosing Cholangitis?

Primary Sclerosing Cholangitis (PSC) is a rare, chronic liver disease characterized by inflammation and scarring of the bile ducts inside and outside the liver. Over time, the bile ducts become narrowed or blocked, leading to bile buildup, liver damage, and potentially liver failure. PSC is often associated with inflammatory bowel diseases, particularly ulcerative colitis. Common symptoms include fatigue, itching, abdominal discomfort, and jaundice, although some patients remain asymptomatic for years. Currently, there is no cure for PSC, and treatment focuses on managing symptoms, preventing complications, and, in advanced cases, liver transplantation.

Download the report to understand which factors are driving Primary Sclerosing Cholangitis Epidemiology Trends @ Primary Sclerosing Cholangitis Prevalence

Primary Sclerosing Cholangitis Epidemiology Segmentation

The Primary Sclerosing Cholangitis epidemiology section provides insights into the historical and current Primary Sclerosing Cholangitis patient pool and forecasted trends for the leading markets. The Primary Sclerosing Cholangitis market report proffers epidemiological analysis for the study period 2020–2034 in the leading markets, segmented into:

  • Diagnosed PSC Prevalence Across the 7MM

  • Gender-Based PSC Prevalence in the 7MM

  • Symptom-Specific PSC Patient Distribution in the 7MM

  • Comorbidity-Associated PSC Cases in the 7MM

Download the sample page to understand which factors are driving Primary Sclerosing Cholangitis Epidemiology Trends @ Primary Sclerosing Cholangitis Prevalence

Scope of the Primary Sclerosing Cholangitis Market Report

  • Coverage- 7MM

  • Study Period- 2020-2034

  • Forecast Period- 2024-2034

  • Primary Sclerosing Cholangitis companies: Gilead Sciences, Phenex Pharmaceuticals, HighTide Therapeutics, Dr. Falk Pharma, Mirum Pharmaceuticals, Pliant Therapeutics, Inc, NGM Biopharmaceuticals, CymaBay Therapeutics, Chemomab Therapeutics, and others.

  • Therapeutic Assessment: Primary Sclerosing Cholangitis current marketed and emerging therapies

  • Primary Sclerosing Cholangitis Market Dynamics: Key Market Forecast Assumptions of Emerging Primary Sclerosing Cholangitis Drugs and Market Outlook

  • Competitive Intelligence Analysis: SWOT analysis and Market entry strategies

  • Unmet Needs, KOL’s views, Analyst’s views, Primary Sclerosing Cholangitis Market Access and Reimbursement

Table of Contents

1. Primary Sclerosing Cholangitis Market Key Insights

2. Primary Sclerosing Cholangitis Market Report Introduction

3. Primary Sclerosing Cholangitis Market Overview at a Glance

4. Primary Sclerosing Cholangitis Market Executive Summary

5. Disease Background and Overview

6. Primary Sclerosing Cholangitis Treatment and Management

7. Primary Sclerosing Cholangitis Epidemiology and Patient Population

8. Patient Journey

9. Primary Sclerosing Cholangitis Marketed Drugs

10. Primary Sclerosing Cholangitis Emerging Drugs

11. Seven Major Primary Sclerosing Cholangitis Market Analysis

12. Primary Sclerosing Cholangitis Market Outlook

13. Potential of Current and Emerging Therapies

14. KOL Views

15. Unmet Needs

16. SWOT Analysis

17. Appendix

18. DelveInsight Capabilities

19. Disclaimer

20. About DelveInsight

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Abhishek kumar
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: https://www.delveinsight.com/report-store/primary-sclerosing-cholangitis-market
Country: United States
Website: https://www.delveinsight.com/report-store/primary-sclerosing-cholangitis-market

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Primary Sclerosing Cholangitis Market is Projected to Boom by 2034 Owing to the Launch of Novel Therapies | DelveInsight

Malignant Ascites Market is Expected to Witness Significant Growth by 2036 Owing to the Launch of Novel Therapies | DelveInsight

The market dynamics for Malignant Ascites are witnessing considerable growth driven by increasing prevalence of associated cancers, rising demand for effective symptomatic therapies, and advancements in targeted and immunotherapeutic treatment approaches. Additionally, the launch of emerging therapies such as M701 (Wuhan YZY Biopharma), Catumaxomab, and others will further fuel the market.

DelveInsight, a leading market research firm, announces the release of its latest report, “DelveInsight’s Malignant Ascites Market Insights, Epidemiology, and Market Forecast 2036.” This comprehensive report provides an in-depth understanding of Malignant Ascites, including historical and forecasted epidemiology, market trends, and treatment scenarios across the United States, EU4 (Germany, Spain, Italy, France), the United Kingdom, and Japan.

Key Takeaways from the Malignant Ascites Market

  • The market size for Malignant Ascites in the leading markets is expected to grow significantly by 2036.

  • The United States accounted for the highest Malignant Ascites treatment market size in 7MM in 2025, in comparison to the other major markets, i.e., EU4 countries, the United Kingdom, and Japan.

  • In 2020, the total incident cases of Malignant Ascites associated cancers were 1.6 million in the 7MM.

  • Among all the associated cancers, the highest incident cases were reported in Breast Cancer. In 2020, the total incident cases of Breast Cancer were ~640,000.

  • According to Ikegami et al. (2024), Malignant Ascites accounts for about 10% of all cases of ascites and is most frequently associated with ovarian cancer, while gastric, uterine, breast, colorectal, and pancreatic cancers together account for 80% of cases.

  • According to Han & Borazanci (2023), up to 30% of patients with pancreatic ductal adenocarcinoma (PDAC) develop Malignant Ascites.

  • Leading Malignant Ascites companies, such as Wuhan YZY Biopharma, LINDIS Biotech GmbH, Pharmanovia, and others, are developing new Malignant Ascites treatment drugs that can be available in the Malignant Ascites market in the coming years.

  • The promising Malignant Ascites therapies in clinical trials include M701 and others.

Keen to know more about the market? Request our sample page athttps://www.delveinsight.com/sample-request/malignant-ascites-market

Key Factors Driving the Malignant Ascites Market

Increasing Prevalence of Associated Cancers: The growing incidence of ovarian, pancreatic, breast, colorectal, gastric, and liver cancers is significantly contributing to the rise in Malignant Ascites cases worldwide.

Rising Demand for Effective Symptomatic Therapies: Patients with Malignant Ascites frequently experience abdominal swelling, pain, nausea, dyspnea, and reduced appetite, creating demand for more effective therapies that improve quality of life and reduce repeated hospitalizations.

Advancements in Targeted and Immunotherapeutic Approaches: Emerging therapies including bispecific antibodies, intraperitoneal immunotherapies, and oncolytic virotherapy are expected to improve treatment outcomes and reshape the future Malignant Ascites treatment landscape.

Malignant Ascites Competitive Landscape

Several Malignant Ascites drugs in development include M701 (Wuhan YZY Biopharma), Catumaxomab, and others.

These candidates target diverse mechanisms such as EpCAM-directed bispecific antibody therapy, T-cell activation, and targeted immune-mediated tumor cell killing, aiming to improve puncture-free survival, overall survival, and symptom management in patients with Malignant Ascites.

Discover more about therapies set to grab major Malignant Ascites market share @ Malignant Ascites Treatment Landscape

Recent Developments in the Malignant Ascites Market

  • In February 2025, LINDIS Biotech GmbH and Pharmanovia announced that catumaxomab received marketing authorization from the European Commission to treat Malignant Ascites in adults with EpCAM-positive carcinomas.

  • In October 2024, Catumaxomab received a positive opinion from the EMA’s Committee for Medicinal Products for Human Use (CHMP).

  • In December 2025, Wuhan YZY Biopharma announced that Phase II clinical trial data for M701 demonstrated longer puncture-free survival (75 vs. 25 days) and improved overall survival compared with controls.

What is Malignant Ascites?

Malignant Ascites is the abnormal accumulation of fluid in the peritoneal cavity caused by cancer. It is commonly associated with advanced-stage malignancies such as ovarian, pancreatic, breast, colorectal, gastric, and liver cancers. Patients often experience abdominal distention, pain, nausea, shortness of breath, reduced appetite, and impaired quality of life. The pathogenesis of Malignant Ascites is multifactorial and involves increased vascular permeability, impaired lymphatic drainage, and tumor-related inflammation.

Malignant Ascites Epidemiology Segmentation

The Malignant Ascites epidemiology section provides insights into the historical and current Malignant Ascites patient pool and forecasted trends for the leading markets. The Malignant Ascites market report proffers epidemiological analysis for the study period 2022–2036 in the leading markets, segmented into:

  • Total Incident Cases of Malignant Ascites Associated Cancers

  • Total Patient Pool of Malignant Ascites

  • Indication-wise Patient Pool of Malignant Ascites

Scope of the Malignant Ascites Market Report

  • Therapeutic Assessment: Malignant Ascites current marketed and emerging therapies

  • Malignant Ascites Market Dynamics: Key Market Forecast Assumptions of Emerging Malignant Ascites Drugs and Market Outlook

  • Key Companies: Wuhan YZY Biopharma, LINDIS Biotech GmbH, Pharmanovia, and others

  • Key Therapies: M701, Catumaxomab, OK-432, KM-CART, Chemotherapy, Concomitant Diuretic Therapy, and others

  • Competitive Intelligence Analysis: SWOT analysis and Market entry strategies

  • Unmet Needs, KOL’s views, Analyst’s views, Malignant Ascites Market Access and Reimbursement

To know more about Malignant Ascites companies working in the treatment market, visit @ Malignant Ascites Clinical Trials and Therapeutic Assessment

Table of Contents

  1. Malignant Ascites Market Report Introduction

  2. Executive Summary for Malignant Ascites

  3. SWOT Analysis of Malignant Ascites

  4. Malignant Ascites Patient Share (%) Overview at a Glance

  5. Malignant Ascites Market Overview at a Glance

  6. Malignant Ascites Background and Overview

  7. Malignant Ascites Epidemiology and Patient Population

  8. Country-Specific Patient Population of Malignant Ascites

  9. Malignant Ascites Current Treatment and Medical Practices

  10. Malignant Ascites Unmet Needs

  11. Malignant Ascites Emerging Therapies

  12. Malignant Ascites Market Outlook

  13. Country-Wise Malignant Ascites Market Analysis (2022–2036)

  14. Malignant Ascites Market Access and Reimbursement of Therapies

  15. Malignant Ascites Market Drivers

  16. Malignant Ascites Market Barriers

  17. Malignant Ascites Appendix

  18. Malignant Ascites Report Methodology

  19. DelveInsight Capabilities

  20. Disclaimer

  21. About DelveInsight

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kirti Sharma
Email: Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: https://www.delveinsight.com/consulting/due-diligence-services
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Malignant Ascites Market is Expected to Witness Significant Growth by 2036 Owing to the Launch of Novel Therapies | DelveInsight

Stocks to Watch: ANY, CMND, PRFX, OLOX, IGC Data Centers, AI, Quantum & Healthcare

As artificial intelligence, quantum computing, energy infrastructure, and next-generation healthcare technologies continue attracting investor attention, several emerging companies are positioning themselves at the intersection of some of the market’s fastest-growing sectors. Investors are increasingly watching companies involved in AI infrastructure, power generation, renewable energy optimization, quantum connectivity, and AI-powered biotechnology.

Sphere 3D Corp. (NASDAQ: ANY) is drawing attention following its advancement of an AI infrastructure and power platform spanning Tennessee, Kentucky, and Iowa. As AI adoption accelerates, industry experts increasingly point to power availability—not semiconductors—as the next major bottleneck for data center expansion. With electricity demand from AI-driven data centers projected to rise significantly over the coming decade, Sphere 3D is positioning itself around energized infrastructure and available power capacity, potentially benefiting from growing demand for AI-ready deployment sites.

Clearmind Medicine Inc. (NASDAQ: CMND) recently announced a Japanese patent application covering its proprietary MEAI-based depression treatment. The clinical-stage biotech company is developing non-hallucinogenic neuroplastogen therapies designed as potentially safer alternatives to traditional antidepressants and psychedelic-based treatments, further expanding its global intellectual property portfolio.

QTREX Quantum Ltd. (NASDAQ: QTEX) is focused on advanced connectivity solutions supporting next-generation quantum computing and mission-critical electronics applications. Following the acquisition of its Advanced Micro Engineering (AME) platform, the company is developing high-density quantum connectivity systems designed for dilution cryostats while expanding applications across aerospace, defense, satellite, and missile technologies. QTEX also continues advancing medical technology initiatives alongside efforts to monetize portions of its healthcare portfolio.

PRF Technologies Ltd. (NASDAQ: PRFX) recently provided an update on DeepSolar Predict, its AI-driven renewable energy optimization platform. The technology integrates weather intelligence, battery storage orchestration, and real-time energy market analytics to help solar, wind, and energy storage operators maximize revenue and operational efficiency. The platform participates in NVIDIA’s Connect Program and is supported by proprietary patent-pending micro-climate modeling technology.

Olenox Industries Inc. (NASDAQ: OLOX) is building a diversified energy platform through acquisitions and operational expansion across the oil and gas, energy services, and energy technology sectors. The vertically integrated company is focused on acquiring and optimizing strategic energy infrastructure assets across key U.S. markets as demand for reliable energy generation and industrial power continues to grow.

IGC Pharma, Inc. (NYSE American: IGC) continues expanding its Artificial Intelligence strategy within the healthcare sector. The clinical-stage biotechnology company is leveraging AI-powered analytics, precision medicine, and advanced data harmonization technologies to accelerate Alzheimer’s disease drug development. The company recently filed additional patent applications related to its proprietary AI-based AHA platform designed to improve clinical trial analysis, patient targeting, and pharmaceutical research.

With themes including Artificial Intelligence, Data Centers, Quantum Computing, Renewable Energy, Energy Infrastructure, Alzheimer’s Research, Precision Medicine, Healthcare Technology, Defense Technology, and Advanced Manufacturing, companies such as ANY, IGC, CMND, PRFX, and OLOX are positioning themselves within sectors expected to remain key areas of investor focus throughout 2026.

 

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor’s investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content.”TSR” is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. “TSR” authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. “TSR” has not been compensated to produce content related to “Any Companies” appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email: Send Email
Country: United States
Website: http://www.thestreetreports.com

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Stocks to Watch: ANY, CMND, PRFX, OLOX, IGC Data Centers, AI, Quantum & Healthcare

Hexane Market Size, Future Prospects, and Industry Trends: A Detailed Analysis 2026-2031 | Expert Review

The hexane market is witnessing steady growth, supported by its extensive use in edible oil extraction, pharmaceuticals, adhesives, and industrial cleaning applications. Market players are focusing on production efficiency, regulatory compliance, and sustainable alternatives to address environmental concerns. Growing industrial demand and expanding manufacturing activities are expected to create significant opportunities for leading companies in the coming years.

The Global Hexane Market is projected to grow from USD 2.95 billion in 2026 to USD 3.64 billion by 2031, at a CAGR of 4.3% during the forecast period. The report delivers in-depth insights into key market dynamics, including regional growth trends, hexane market demand, market segmentation, CAGR projections, and the revenue performance of leading industry players. Hexane is a widely used organic solvent obtained during the refining of petroleum and belongs to the class of saturated hydrocarbons. It is a colorless, volatile liquid composed of different isomers, including n-hexane, isohexane, and neohexane, each offering distinct performance characteristics depending on the application. Due to its low boiling point, high evaporation rate, and strong ability to dissolve oils and greases, hexane is extensively applied across multiple industries. It plays a crucial role in oilseed processing, where it is used to efficiently extract edible oils, and is also valued in industrial cleaning, adhesives, coatings, and polymer manufacturing processes.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=91763483

The market growth for hexane is primarily influenced by rising demand across food, pharmaceutical, and industrial sectors. The increasing global need for edible oils, driven by population growth and changing dietary patterns, remains a key factor supporting consumption. At the same time, expanding manufacturing activities have boosted the use of hexane in cleaning and degreasing operations, particularly in automotive and machinery production. In the pharmaceutical industry, hexane is utilized in extraction and purification processes, contributing further to its steady demand. Additionally, growth in polymerization and rubber processing applications continues to create new opportunities. However, environmental and health concerns related to prolonged exposure are prompting regulatory oversight, encouraging industries to adopt improved safety standards while maintaining reliance on hexane for its cost efficiency and functional advantages.

By grade, the oil extraction/food grade segment is expected to account for the largest market share, in terms of value, during the forecast period.

The oil extraction/food-grade segment is expected to account for the largest share of the hexane market by value during the forecast period, mainly due to its indispensable role in edible oil production and its high-volume, continuous demand. Food-grade hexane is widely used for extracting oils from crops like soybean and sunflower because of its efficiency, cost-effectiveness, and high recovery rates, which significantly enhance processing economics for manufacturers. The segment’s dominance is further supported by rising global consumption of vegetable oils, driven by population growth, urbanization, and increasing demand for processed foods. In addition, compliance with food safety standards gives this grade a strong advantage over alternatives, ensuring consistent adoption across large-scale food processing industries and reinforcing its leading position in the market.

By application, the oil extraction segment is estimated to account for the largest market share, in terms of value, during the forecast period.

The oil extraction segment, by application, is expected to hold the largest share of the hexane market in value terms during the forecast period due to its extensive use in processing oilseeds at an industrial scale. Hexane’s strong solvency, low boiling point, and compatibility with efficient recovery systems make it the preferred solvent for extracting edible oils, enabling high yields and cost optimization for producers. The segment’s dominance is largely driven by the steadily increasing global demand for vegetable oils, supported by population growth, expanding food processing industries, and rising consumption of packaged and convenience foods. Additionally, the scalability of extraction operations and continuous processing requirements ensures consistent, high-volume utilization of hexane, reinforcing the segment’s leading market position.

Get a Sample Copy of This Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=91763483

Asia Pacific is projected to account for the largest market share during the forecast period in terms of value.

The Asia Pacific region is expected to account for the largest share of the hexane market by value during the forecast period, primarily due to its strong presence in edible oil production and expanding industrial base. Countries such as China and India are major consumers of vegetable oils, driving significant demand for hexane in large-scale oil extraction processes. Rapid population growth, increasing urbanization, and rising consumption of processed foods further amplify this demand. Additionally, the region’s growing manufacturing sectors, including pharmaceuticals, chemicals, and polymers, contribute to higher hexane usage. Cost-effective production capabilities and the availability of raw materials also support regional market dominance, ensuring that Asia Pacific maintains its leading position in terms of value.

Hexane Companies

China Petrochemical Corporation (Sinopec) (China), Shell plc. (London), Exxon Mobil Corporation (US), Chevron Phillips Chemical Company (US), and Junyuan Petroleum Group (China) are the major players in the market.

China Petrochemical Corporation ( Sinopec) (China)

Sinopec is one of the major integrated oil refining and petrochemical enterprises operating across key segments, such as exploration & production, refining, chemicals, marketing & distribution, and corporate & others. Within its chemicals division, the company manufactures a broad range of petrochemical intermediates, including synthetic rubber, resins, and specialty oils, which serve as key inputs for producing rubber extender oils widely used in the tire and rubber industries. To comply with the European Directive 2005/69/EC, which limits the content of Benzo(a)pyrene (B(a)P), polycyclic aromatic hydrocarbons (PAHs), and polycyclic aromatics (PCA) in extender oils for tire manufacturing, Sinopec developed the Aromatic Rubber Extender Oil Extraction (ARE) process. This technology, commercialized at the Sinopec Jinan Refinery, enables the production of environmentally compliant extender oils that meet the European Directive standards. The ARE-derived products are now utilized by multiple rubber and tire manufacturers, supporting the shift toward cleaner and safer tire production. The company has a geographical presence in Mainland China, Singapore, and Others.

Shell plc. (London)

Shell plc is a global energy and petrochemical powerhouse operating in over 70 countries. Its operations span oil & gas exploration, production, LNG supply, refining, petrochemical manufacturing, and worldwide marketing of fuels and lubricants. The company is also advancing into renewables, hydrogen, carbon capture, and other energy transition technologies as core to its long-term strategy.

Shell operates through six key segments: Integrated Gas (natural gas production, LNG supply chains, and global marketing); Upstream (crude oil, natural gas, and NGL exploration/extraction with supporting infrastructure); Marketing (fuels, lubricants, biofuels, mobility services, EV charging, and retail stations); Chemicals and Products (refineries and plants producing intermediates and finished goods for industrial, transport, and consumer use); Renewables and Energy Solutions (power generation/trading, hydrogen, CCS hubs, and nature-based carbon initiatives); and Corporate. It maintains a strong regional footprint in North America, Europe, the Middle East & Africa, and Asia Pacific.

Exxon Mobil Corporation (US)

Exxon Mobil Corporation stands as one of the world’s largest integrated energy and chemical companies, boasting over 140 years of history and operations in more than 50 countries. Its diverse portfolio encompasses oil and gas exploration/production, refining, fuels marketing, petrochemical manufacturing, and specialty products under iconic brands like Exxon, Mobil, Esso, and XTO.

The company structures its operations into four main segments: Upstream, Energy Products, Chemical Products, and Specialty Products to supply energy, lubricants, and essential chemical materials for global industries and daily life. While advancing traditional operations, ExxonMobil is ramping up investments in low-carbon solutions, including carbon capture, hydrogen, biofuels, and advanced materials. It maintains a global footprint across the Americas, Europe, Asia Pacific, the Middle East, and Africa.

Chevron Phillips Chemical Company (US)

Chevron Phillips Chemical Company LLC (CPChem) is a petrochemical joint venture formed in 2000 and equally owned by Chevron U.S.A. Inc. and Phillips 66 Company. CPChem manufactures and markets a broad range of petrochemical products derived from hydrocarbons. Its business is organized into key segments that include olefins, polyolefins, aromatics, normal alpha olefins, polyalphaolefins, drilling specialties, and specialty chemicals. These segments cover foundational chemical building blocks such as ethylene and propylene, as well as downstream derivatives like polyethylene and other performance chemicals used as industrial inputs across manufacturing value chains. Hexane is part of CPChem’s hydrocarbon and solvent-related product portfolio and is used in industrial applications such as extraction and chemical processing within its broader petrochemical operations.

Inquire Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=91763483

The company operates as a globally integrated producer with manufacturing and research facilities located across multiple regions. Its geographic footprint includes operations in the US, Puerto Rico, Singapore, China, South Korea, Saudi Arabia, Qatar, Mexico, and Belgium. These operations are grouped within broader regional structures spanning North America, Europe, the Middle East, and Asia Pacific, reflecting its multinational production and distribution network. This geographic presence supports the company’s ability to supply products such as hexane and other petrochemical materials to a wide range of industrial markets globally.

Junyuan Petroleum Group (China)

Junyuan Petroleum Group is a China-based petrochemical enterprise that has developed into a multi-subsidiary organization with an integrated oil refining and chemical production chain. The group has expanded through several affiliated companies covering petrochemical technology, logistics, and trade, forming a vertically integrated structure. Its core business segments are centered on the production and processing of hydrocarbon-based chemicals and solvents, including propane and butane series, pentane and hexane series, solvent oil series, aromatic chemicals, environmentally oriented D-series solvents, and hydrocracked naphtha products. These product lines are supported by in-house manufacturing, logistics, and distribution capabilities, alongside activities in chemical additive production, such as sulfurized agents used in petrochemical refining. Collectively, these segments reflect an industrial focus on solvent manufacturing, specialty chemical production, and supporting supply chain operations within the broader petrochemical value chain.

Geographically, the company’s operations are anchored in China, with its primary production base located in Shandong and market coverage extending across multiple domestic regions, including northeast, north, northwest, and southern China. Beyond its domestic footprint, the group maintains an international presence through exports and global sales networks. According to its official information, its products are supplied to markets in the Middle East, Europe, the Americas, Africa, and broader Asia, indicating a diversified geographic reach across both developed and emerging regions.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: https://www.marketsandmarkets.com/Market-Reports/hexane-market-91763483.html
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/hexane-market-91763483.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Hexane Market Size, Future Prospects, and Industry Trends: A Detailed Analysis 2026-2031 | Expert Review

Aliphatic Hydrocarbon Solvents & Thinners Market Size, Growth Prospects, and Regional Analysis: A Comprehensive Report 2026-2032

The aliphatic hydrocarbon solvents and thinners market is witnessing steady growth, driven by increasing demand from paints & coatings, adhesives, printing inks, and industrial cleaning applications. Key companies are investing in product innovation, regulatory compliance, and sustainable solutions to enhance competitiveness. Growing industrialization and infrastructure development are expected to create significant growth opportunities across global markets.

The Global Aliphatic Hydrocarbon Solvents & Thinners Market is expected to reach USD 6.81 billion by 2032, from USD 5.26 billion in 2026, at a CAGR of 4.4% during the forecast period. The report delivers in-depth insights into key market dynamics, including regional growth trends, aliphatic hydrocarbon solvents and thinners market demand, market segmentation, CAGR projections, and the revenue performance of leading industry players.

The market shows consistent growth as demand continues to increase across the paint, coatings, adhesives, and industrial cleaning sectors. The construction sector, infrastructure development, and increased vehicle manufacturing are driving greater use of solvent-based products. Various industrial processes require these solvents to achieve optimal formulation results, complete degreasing tasks, and produce top-quality surface finishes. Market demand continues to increase as emerging economies experience manufacturing growth, and applications such as paints & coatings and adhesives drive high demand for aliphatic solvents. The aliphatic hydrocarbon solvents and thinners market will continue to expand because industries require effective and dependable solvent solutions.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=155300623

By type, the mineral spiritssegment is expected to account for the largest market share, in terms of value, during the forecast period.The mineral spirits segment in the aliphatic hydrocarbon solvents and thinners market holds a dominant market position because it serves diverse industrial and commercial needs across sectors. Paints and coatings use these solvents because they help control viscosity and improve application properties, leading to consistent, smooth finishes. The maintenance and industrial processes use these products because they effectively remove dirt and oil from surfaces. Mineral spirits are useful because they evaporate at a consistent rate and work well with various chemical mixtures. The construction sector, together with the automotive industry and the broader manufacturing sector, drives the increasing use. The product’s ability to perform multiple functions at low cost drives high market demand.

By application, the adhesives segment is projected to register the highest growth in the aliphatic hydrocarbon solvents and thinners market, in terms of value, during the forecast period.

The adhesives segment in the aliphatic hydrocarbon solvents and thinners market is witnessing high growth due to rising demand for efficient bonding solutions across various industries. The solvents serve a dual purpose in adhesive manufacturing as they function to control adhesive viscosity while enabling smooth adhesive application and providing consistent adhesive distribution. The packaging, construction, and automotive industries are increasing their use of adhesives, which leads to higher adhesive consumption. The demand for dependable solvent solutions is increasing because of the trend toward lightweight materials and new bonding methods. The expanding industrial base in developing regions, combined with rising manufacturing activities, creates more demand for products. Aliphatic solvents help improve formulation performance and application efficiency, thereby driving growth in this product category.

Asia Pacific is projected to account for the largest market share in terms of value during the forecast period.

The Asia Pacific region holds the largest market share in the aliphatic hydrocarbon solvents and thinners market because its industrial base drives high consumption across essential industries. Countries such as China, India, Japan, and South Korea together make a major contribution through their growing manufacturing and processing sectors. Solvent consumption in the region increases because construction activities and paint and coating products experience higher demand. The existing petrochemical facilities provide both a consistent supply of raw materials and extensive manufacturing capacity. The market will continue to be dominated by the region because of its ongoing urban development and economic growth.

Aliphatic Hydrocarbon Solvents & Thinners Companies

Some of the leading players in this market include ExxonMobil Corporation (US), Shell plc (UK), Phillips 66 (US), SK Geocentric Co., Ltd. (South Korea), and Calumet, Inc. (US).

ExxonMobil Corporation (US)

ExxonMobil Corporation operates as one of the largest energy and petrochemical companies, trading publicly on international stock markets. The company conducts its business operations through exploration and production activities, which lead to refining operations and subsequent marketing of crude oil & natural gas, petroleum products, petrochemicals, and specialty products. ExxonMobil operates in over 60 countries because it provides essential energy and chemical products for worldwide transportation, manufacturing, and industrial processes.

Get a Sample Copy of This Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=155300623

The company conducts its business through an integrated model, which combines upstream oil & gas extraction with downstream operations that include refining, chemical production, and development of low-carbon energy solutions. The company uses its integrated system to achieve maximum resource efficiency while sustaining operational performance and delivering diverse energy and chemical solutions to customers worldwide. The company sells its products through four distinct segments, which are Energy Products, Upstream, Chemical Products, and Specialty Products. The Standard Oil Company, which was founded in the late 1800s, is the predecessor of ExxonMobil. The 1911 Standard Oil breakup resulted in the making of two successor companies, which later became Exxon and Mobil through their previous names, Standard Oil of New Jersey and Standard Oil of New York. The 1999 merger of the two companies created ExxonMobil, which now stands as one of the leading energy companies worldwide. ExxonMobil produces an extensive range of energy and chemical products, which include crude oil, natural gas, gasoline, diesel, jet fuel, marine fuels, base oils, finished lubricants, petrochemicals, and others. ExxonMobil maintains a strong global footprint with upstream, refining, chemical, and marketing operations across multiple regions, including North America, Latin America, Europe, the Middle East, Asia Pacific, and Africa.

Shell plc (UK)

Shell plc operates as a worldwide energy and petrochemical corporation that manages operations throughout all stages of hydrocarbon production. Shell operates an integrated business model that extends throughout the complete hydrocarbon production process, which includes upstream oil and gas extraction to liquefied natural gas (LNG) operations, refining, fuels distribution, petrochemical production, and new low-carbon energy development. The company maintains a global infrastructure and advanced technology, which helps it meet global energy requirements while funding energy transition projects.

The company began in the 19th century when the Shell Transport and Trading Company and Royal Dutch Petroleum Company merged in 1907 to establish Royal Dutch Shell. The company simplified its corporate structure by changing its name to Shell and establishing its main office in London in 2022. The company conducts its operations through five business segments: Upstream, Integrated Gas, Chemicals Products, Renewables Energy Solutions, and Marketing. Shell operates one of the largest global energy networks, which extends across Europe, North America, Asia Pacific, the Middle East, Africa, and Latin America.

Phillips 66 (US)

Phillips 66 is a leading American energy company that integrates multiple energy sectors through its refining, midstream, chemical production, and specialized product marketing operations. The company produces fuels and petrochemicals, which are essential components for various transportation, industrial, and consumer applications worldwide. Phillips 66 produces and sells products for multiple industries, including transportation, mobility, petrochemicals, plastics, manufacturing, processing, aviation, marine fuel, construction, and infrastructure.

SK Geocentric Co., Ltd. (South Korea)

SK Geocentric Co., Ltd. is a South Korean petrochemical and advanced recycling enterprise and a major subsidiary of SK Innovation Co., Ltd. within SK Group. The company is engaged in the manufacturing of petrochemical materials, high-performance polymers, and sustainable plastic solutions, while developing its circular economy programs and advanced plastic recycling technologies. The company maintains its worldwide operations to deliver chemical materials essential for various industries, including packaging, automotive, electronics, construction, and consumer goods. SK Geocentric has transformed itself into a sustainable chemical enterprise that integrates petrochemical production, plastic recycling, and sustainable materials research.

SK Geocentric was previously called SK Global Chemical, which served as the petrochemical division of SK Innovation. SK Geocentric produces a wide range of petrochemical products and polymer materials that serve as feedstocks for numerous industrial and consumer applications. These materials are used in packaging, automotive components, construction materials, electronic devices, and industrial manufacturing processes. SK Geocentric maintains a strong international presence through its production plants and research facilities, as well as strategic alliances operating across various global sites. The company operates its manufacturing facilities mainly in South Korea, China, the US, and Europe.

Inquire Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=155300623

Calumet, Inc. (US)

Calumet, Inc. is a US-based manufacturer and refiner that focuses on producing specialty hydrocarbon products, fuels, lubricants, solvents, waxes, and renewable fuels. The company, which operates from its Indianapolis headquarters, develops and markets various specialty materials used in industrial applications, automotive applications, and consumer products across the globe. The company has progressed from its origins as a small petroleum refining business into its current status as a major manufacturer of specialized hydrocarbon products. The company operates its refining, blending, and packaging facilities throughout North America and delivers products to more than 90 countries, including thousands of industrial clients operating worldwide.

The company specializes in producing specialty products rather than traditional commodity fuels, enabling it to create high-value hydrocarbon products that serve as base materials for various end-use applications, including adhesives, paints & coatings, lubricants, and personal care products. Its main product categories consist of base oils, process oils, specialty solvents, hydrocarbons, synthetic finished lubricants, paraffin, microcrystalline waxes, asphalt, fuel products, and renewable fuels. The company operates more than 10 facilities throughout North America that produce, blend, and package products, creating a complete network of refining and specialized product manufacturing operations.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: https://www.marketsandmarkets.com/Market-Reports/aliphatic-hydrocarbon-solvents-and-thinners-market-155300623.html
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/aliphatic-hydrocarbon-solvents-and-thinners-market-155300623.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Aliphatic Hydrocarbon Solvents & Thinners Market Size, Growth Prospects, and Regional Analysis: A Comprehensive Report 2026-2032

Probiotic Supplement Market to Reach USD 16.69 Billion by 2031, Growing at a CAGR of 9.5% – Exclusive Report by MarketsandMarkets™

“MarketsandMarkets™”
Probiotic Supplements Market by Product Form (Tablets, Capsules, Powder, Gummies & Chewable, Liquid, and Other Product Forms), Health Application, End User, Distribution Channel, Ingredient (Bacteria & Yeast), and Region – Global Forecast to 2031

According to a research report published by MarketsandMarkets™, the probiotic supplements market is projected to grow from USD 10.60 billion in 2026 and to reach USD 16.69 billion by 2031, at a Compound Annual Growth Rate (CAGR) of 9.5% during the forecast period.

Market Size and Growth Forecast

  • Market Size in 2025 (Value): USD 9.73 Billion
  • Market Forecast in 2031 (Value): USD 16.69 Billion
  • Growth Rate: CAGR of 9.5% from 2026 to 2031
  • Years Considered: 2022–2031
  • Base Year: 2025
  • Forecast Period: 2026–2031
  • Units Considered: Value (USD Million/Billion), Volume (KT)
  • Report Coverage: Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, and Trends

 

Probiotic Supplements Market

 

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=207657789

By product form, capsules segment to lead market during forecast period.

Capsules are projected to lead the probiotic supplements market during the forecast period owing to their superior stability, accurate dosage delivery, extended shelf life, and strong consumer preference across multiple wellness applications. Capsule formulations are widely utilized in digestive health, immunity support, women’s health, metabolic wellness, and overall microbiome management due to their ability to effectively protect probiotic strains from environmental exposure and maintain product efficacy throughout the product lifecycle.

Manufacturers increasingly prefer capsule-based formulations because they support multi-strain combinations, delayed-release technologies, and advanced encapsulation methods that improve probiotic survivability through the gastrointestinal tract. In addition, capsules offer convenience, portability, and ease of consumption, making them highly preferred among adult consumers globally. Growing availability of vegetarian capsules, clean-label formulations, and clinically validated probiotic products is further strengthening the segment’s market position across pharmacies, drugstores, specialty wellness stores, and online channels.

By health application, digestive health segment to lead market during forecast period.

Digestive health is projected to remain the leading application segment in the probiotic supplements market during the forecast period due to increasing consumer awareness regarding gut microbiome balance, gastrointestinal wellness, and preventive digestive care. Consumers are increasingly adopting probiotic supplements to improve digestion, support healthy gut flora, reduce digestive discomfort, and maintain overall intestinal health as part of long-term wellness routines.

The growing prevalence of digestive disorders, changing dietary habits, rising stress levels, and increasing consumption of processed foods are further contributing to the strong demand for digestive health probiotic supplements globally. Manufacturers are continuously introducing advanced formulations containing Lactobacilli, Bifidobacterium, Bacillus, and Saccharomyces boulardii strains designed specifically for digestive wellness applications. Increasing scientific research supporting probiotic efficacy in digestive health management and rising consumer preference for natural wellness products are expected to further strengthen segment growth over the forecast period.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=207657789

By end user, adults segment to account for largest market share during forecast period.

Adults are projected to account for the largest share of the probiotic supplements market during the forecast period, owing to increasing health awareness, rising preventive healthcare adoption, and growing demand for daily nutritional supplementation. Adult consumers are increasingly incorporating probiotic supplements into their wellness routines to support digestive health, immunity enhancement, metabolic wellness, women’s health, and overall microbiome balance.

Factors such as busy lifestyles, unhealthy diet patterns, stress-related digestive concerns, and increasing focus on long-term health management are driving strong demand for probiotic supplements among adult populations globally. Manufacturers are also introducing targeted probiotic formulations for specific adult health concerns, including digestive comfort, energy support, immunity management, and healthy aging. Increasing accessibility of probiotic supplements through pharmacies, specialty wellness stores, and e-commerce platforms is further supporting the dominance of the adult segment in the global market.

By ingredient, Lactobacilli segment to dominate market during forecast period.

Lactobacilli are projected to dominate the probiotic supplements market during the forecast period owing to their extensive clinical support, broad application range, and high consumer awareness across multiple wellness categories. These probiotic strains are widely recognized for their role in supporting digestive health, enhancement of immunity, women’s health, oral health, and overall microbiome balance, making them one of the most utilized probiotic ingredients globally.

Lactobacilli strains are extensively incorporated into different types of product forms such as capsules, powders, gummies, chewables, tablets, and liquids, due to their formulation flexibility and compatibility across different product formats. Increasing scientific validation regarding their effectiveness in maintaining gut flora and improving digestive wellness is significantly supporting market growth. Furthermore, rising demand for clinically supported probiotic products, clean-label wellness supplements, and personalized nutrition solutions is expected to further strengthen the position of Lactobacilli in the global probiotic supplements market.

Make an Inquiry: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=207657789

Asia Pacific to be fastest-growing regional market for probiotic supplements during forecast period.

The Asia Pacific region is estimated to register the highest CAGR in the probiotic supplements market during the forecast period on account of rising consumer awareness regarding digestive health, immunity, and disease prevention. Increasing income levels, swift urbanization, changing lifestyles, shifting diets, and a growing middle-class population will drive the demand for probiotic supplements in countries such as China, India, Japan, South Korea, and Australia. Functional nutrition products, such as probiotic capsules, gummies, powders, and liquid formats, are gaining popularity among consumers over time owing to rising awareness of health and well-being, and adoption of microbiome-based health products. The growth of the e-commerce sector, increasing acceptance of international probiotic brands, and the rising investment in the nutraceutical and functional food markets are all contributing to the positive growth trends across the Asia Pacific region. Additionally, the rise in personalized nutrition, heightened health awareness among both children and adults, and improved access to retail options through pharmacies, specialty wellness stores, and online platforms are expected to drive consistent regional market growth during the forecast period.

Leading Probiotic Supplements Companies:

The report profiles key players such as Nestlé S.A. (Switzerland), Yakult Honsha Co., Ltd. (Japan), Symrise AG (Germany), Kerry Group plc (Ireland), Herbalife Ltd. (US), Morinaga Milk Industry Co., Ltd. (Japan), Amway Corporation (US), Jarrow Formulas, Inc. (US), Biogaia (Sweden), and others.

Recent Developments in the Probiotic Supplements Industry:

  • October 2025: Yakult Europe B.V. merged Yakult Oesterreich GmbH as part of its strategy to improve operational efficiency and strengthen integration across its European probiotic business operations. The merger supported better coordination of regional activities related to probiotic product distribution, marketing, and business management across European markets.
  • February 2022: Nestlé Health Science completed the acquisition of Vital Proteins to strengthen its position in the global consumer health and nutritional supplements industry. The acquisition supported expansion across functional wellness, gut health, and lifestyle-oriented supplement categories, including probiotic and microbiome-support products.

 

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: https://www.marketsandmarkets.com/Market-Reports/probiotic-supplement-market-207657789.html
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/probiotic-supplement-market-207657789.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Probiotic Supplement Market to Reach USD 16.69 Billion by 2031, Growing at a CAGR of 9.5% – Exclusive Report by MarketsandMarkets™

CIP Chemicals Market Size, Competitive Landscape, and Regional Analysis: A Comprehensive Report 2026-2029

The CIP (Clean-in-Place) chemicals market is expanding steadily due to growing hygiene and sanitation requirements across the food & beverage, pharmaceutical, dairy, and personal care industries. Leading companies are investing in advanced, eco-friendly cleaning solutions to enhance operational efficiency and regulatory compliance. Increasing automation and stringent quality standards are expected to drive sustained market growth and innovation worldwide.

The CIP Chemicals Market size is projected to grow from USD 15.60 billion in 2024 to USD 24.00 billion by 2029, registering a CAGR of 9.0% during the forecast period. The report delivers in-depth insights into key market dynamics, including regional growth trends, CIP chemicals market demand, market segmentation, CAGR projections, and the revenue performance of leading industry players.

The CIP chemicals market is experiencing significant growth due to increasing demand from various major economies for different chemicals in different end use industries such as cosmetics, food & beverage, pharmaceutical & biotechnology and chemicals and other end use industries as well. Growing economies in Europe region and stricter environmental regulations and the need for sustainable practices are driving industries to adopt advanced cleaning methods. Additionally, European authorities have been heavy on industries to embrace environmentally friendly products, which has made manufacturers innovate in developing safer, biodegradable CIP chemicals in further catapulting the CIP chemicals market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=46692551

Acid Cleaners, is expected to be second fastest segment by chemistry during the forecast period.

Acid cleaners, both inorganic acids and organic acids, significantly contribute to the cleaning phase by removing mineral deposits and rust and organic residues that may adulterate product quality and safety. Among the acids used are the phosphoric acid, nitric acid, hydrochloric acid, which forms a part of CIP processes. Phosphoric acid is particularly valuable for its ability to dissolve mineral scales and is normally used as a complementary cleaning agent to alkaline detergents in sequential cleaning processes. It is also applied in dairy processing to remove milk stone and other mineral deposits. Nitric acid is extensively used as it removes corrosion and cleans heat exchangers. Hydrochloric acids are fine for descaling uses.

Single Use Cleaning, is expected to be second largest segment by process type during the forecast period.

One of the major advantages of single-use cleaning methods is the risk reduction associated with cross-contamination. In such product locations where purity is the most important factor, such as in pharmaceutical production, single-use systems prevent residue cleaning agents or contaminants from previous batches from affecting newly produced product. This is indeed a stringent factor when it comes to highly sensitive APIs. Single-use systems can even make it easy to obtain compliance with regulations. As such systems are meant to be used once only, they can be validated more easily than reusable ones to ensure that the essential hygiene standards are met without the complications associated with reusing cleaning solutions. This is especially an advantage in high intensity inspection and quality assurance industries.

Pharmaceutical & biotechnology, is expected to be second largest segment by end-use industry during the forecast period.

The application of different CIP chemicals varies with particular cleaning requirements depending on the applications and equipment used in the pharmaceutical and biotechnology industries. For example, alkaline cleaners, including sodium hydroxide, can easily dissolve and clean away protein and other organic residues and nucleic acids from a bioreactor, whereas acidic cleaners, like phosphoric and nitric acids, have the capabilities to dissolve mineral precipitates in heat exchangers. Sanitizers, such as sodium hypochlorite and chlorine dioxide, are crucial to microorganism elimination and guarantee sterility in drug production. Eco-friendly enzymatic cleaning agents already enhance the breakdown of complex organic materials. Manufacturers who now find a priority in operational efficiency and hygiene standards, that demand specialized biotechnology CIP chemicals is going to increase, fueling further market expansion.

Get a Sample Copy of This Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=46692551

Europe is expected to be the second largest region in the global CIP chemicals market in terms during the forecast period.

The CIP chemicals market in Europe has second largest market share in terms of value. The economic development and growth in various countries in this region lead to an expansion in the Europe CIP chemicals market. The low-priced raw materials, labor, and growing demand by the textile, cosmetics, pharmaceutical & biotechnology, chemicals and food & beverage industries will make this region very attractive for investment by CIP chemicals manufacturers. Europe’s CIP chemicals market offers cleaning and maintenance services for industrial facilities like warehouses, factories, food processing plants among others. The industries realize the realization of clean and sanitary workplaces, which can be achieved with CIP chemicals. The chemicals remove contaminants from surfaces, thereby reducing accidents, providing safety for workers, and promoting their overall productivity in a facility.

CIP Chemicals Companies

To enable an in-depth understanding of the competitive landscape, the report includes the profiles of some of the top players in the CIP chemicals market. These are BASF (Germany), Ecolab (US), DOW (US), Diversey, Inc. (US), Solvay (Belgium), Alfa Laval (Sweden), KERSIA GROUP (France), STOCKMEIER GROUP (Germany), Calvatis GmbH (Germany), Christeyns (Belgium), Zep Inc. (Georgia), Novozymes (Denmark), STERIS (US), Stepan Company (US), Evonik Industries (Germany), GEA Group Aktiengesellschaft (Germany), KIC KRONES Internationale Cooperations-Gesellschaft mbH (Germany), Chemtex Speciality Limited (India), and Keller & Bohacek GmbH & Co. KG (Germany).

ALFA LAVAL is a global leader in manufacturing heat transferring, separating, and fluid handling equipment. Its key products are separators, heat exchangers, pumps, and valves. The company has three operating business segments, namely, marine, energy, and food & water. ALFA LAVAL provides a broad selection of energy-efficient, high-performance systems for air-cooled heat exchange in industrial applications.It also offers customized products for particular applications and operating conditions. The company offers its products and solutions to various industries including chemicals, energy, biotech & pharmaceuticals, food & beverages, marine, transportation, mining, minerals & pigment, machinery & manufacturing, semiconductors & electronics, metallurgy, automotive, and pulp & paper. It also offers several services related to its heat exchangers such as installation, maintenance, and repair. ALFA LAVAL is present in North America, South America, the Middle East & Africa, Asia Pacific and Europe. It has 37 production units in Europe, Asia Pacific, the US, and South America. The company offers sales and services in over 100 countries, has 110 service centers in more than 160 countries, and engages closely with its customers to offer customized business solutions.

BASF has 11 divisions which are categorized into 6 segments namely chemicals, materials, industrial solutions, surface technologies, nutrition & care, agricultural solutions. The Nutrition & Care segment manufactures ingredients and solutions for consumer applications like human and animal nutrition, cleaning agents, and personal care. This segment is encompassed of two major divisions- Care Chemicals and Nutrition & Health. BASF is one of the leading global companies which offer chemical and its solutions. The company operates in 234 production sites worldwide; it manages the 49 global and regional business units and develop strategies for 70 strategic business units.

Inquire Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=46692551

Ecolab is a global leader in sustainable water, hygiene, and infection prevention solutions, serving customers in over 170 countries. Focused on science-driven insights and operational efficiency, they support food safety, environmental health, and resource conservation across food, healthcare, life sciences, hospitality, and industrial markets. Their business covers four main segments: global industrial, global institutional & specialty, global healthcare & life sciences, and others, enabling them to offer customised solutions across diversified customer needs globally. Global healthcare & life sciences is specialized cleaning, sanitizing, and contamination control solutions to the healthcare and personal care and pharmaceuticals. Healthcare operates mostly with the segments infection prevention and surgical products sold mainly to hospitals and surgery centers. Life Sciences offers a wide range of cleaning, sanitizing, and decontamination products, as well as advanced purification solutions primarily supporting pharmaceutical manufacturing and cleanroom environments. Ecolab operates through 32 manufacturing facilities in 14 states in the US. They operate 68 manufacturing facilities internationally in 38 countries.

Novozymes is a global leader in biosolutions: part of the Novonesis Group, it specializes in the exploitation of biotechnology to make sustainable products for many industries. Its business model emphasizes innovation, using a robust portfolio of enzymes and microorganisms to create solutions that improve efficiency while conserving the planet’s precious resources. Novozymes combines an insights-driven approach with a biotech toolbox to create large-scale biosolutions that drive sustainable growth. The company uses a multilateral approach that includes a robust technical service offered to customers to encourage adoption of innovations, a structured distribution network tailored to specific industries, and a good understanding of market needs to ensure the delivery of relevant biosolutions. Companies are present in all major regions and have about 15 production units in different countries.

STERIS is a global leader in products and services that help enhance patient care, focusing on infection prevention. Its solution portfolio includes consumables, such as detergents and instruments; services, like equipment maintenance and microbial reduction; and capital equipment, such as sterilizers and surgical tables. The company operates through three main reportable segments—Healthcare, Applied Sterilization Technologies, and Life Sciences. The Life Sciences segment furnishes products and services for research and manufacturing biopharmaceutical and medical device, particularly in aseptic environments. Offerings include pharmaceutical detergents, cleanroom disinfectants, sterilizers, vaporized hydrogen peroxide decontamination systems, and high-purity water generators. Services include equipment installation, maintenance, upgrades, and repair in all regions with preventive maintenance programs designed to extend equipment life. Company has operations across more than 100 countries in regions like North America, Europe, South America and Asia Pacific.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: https://www.marketsandmarkets.com/Market-Reports/cip-chemicals-market-46692551.html
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/cip-chemicals-market-46692551.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: CIP Chemicals Market Size, Competitive Landscape, and Regional Analysis: A Comprehensive Report 2026-2029

Medical Adhesives Market Size, Sales Volume, Revenue, Price Analysis Report 2026-2031 | Top Key Players Analysis

The medical adhesives market is witnessing significant growth, driven by rising surgical procedures, increasing demand for advanced wound care products, and expanding use of wearable medical devices. Key companies are investing in innovative, biocompatible, and high-performance adhesive technologies to enhance patient outcomes. With ongoing healthcare advancements and growing demand for minimally invasive treatments, the market is expected to experience sustained growth in the coming years.

The Medical Adhesives Market is projected to grow from USD 11.38 billion in 2026 to USD 14.90 billion by 2031, at a CAGR of 5.5% during the forecast period.The report delivers in-depth insights into key market dynamics, including regional growth trends, medical adhesives market demand, market segmentation, CAGR projections, and the revenue performance of leading industry players.

The medical adhesives market experiences continuous growth across Asia Pacific, North America, Europe, the Middle East & Africa, and South America. The growth is due to the expansion of the healthcare industry, and the need for advanced wound care, surgical procedures, and medical devices increases. Medical adhesives, which include acrylics and silicones, cyanoacrylates, and fibrin-based sealants, receive widespread use because they possess biocompatibility and flexibility, which enables them to serve as substitutes for traditional sutures and staples. Asia Pacific experiences its fastest growth rate, with China, India, and Japan leading, while rising healthcare infrastructure, increasing patient population, and growing medical device manufacturing drive the region’s development. North America and Europe sustain strong market demand because their healthcare systems operate advanced surgical methods and strictly enforce regulatory requirements. The Middle East and Africa region expands as healthcare investments rise, while South America experiences growth due to improved access to medical services and better infrastructure. The market will experience steady growth as adhesive technology innovations and global healthcare expansion continue to develop.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=41880473

“Solids hot melt is projected to be the fastest-growing technology segment, in terms of value, during the forecast period.”

The medical adhesives market experiences its fastest expansion through solid hot melt adhesives, which deliver better performance, operational efficiency, and environmental advantages. These adhesives exist as complete solid formulations that require no solvents, resulting in safer, more environmentally friendly products that meet strict healthcare requirements. The products provide instant, strong bonding, which creates excellent product cohesion and flexibility, making them suitable for medical tapes, wearable devices, and wound care products. The production process benefits from solids hot melt adhesives, which enable faster curing. In this way, the organization achieves two goals, which involve reducing production costs and production time. The demand for skin-friendly adhesives in advanced wound care and wearable medical technologies is driving their market expansion. Healthcare manufacturers are adopting solid hot melt technologies because they increasingly need to develop products without solvents and with low VOC emissions, which supports the technology’s rapid growth throughout the prediction period.

“Natural resin will register the highest CAGR, by resin type, during the forecast period.”

The medical adhesives market will experience its highest growth rate during the forecast period as natural resins meet the increasing demand for biocompatible materials that maintain sustainable and skin-safe properties. Natural resins, which come from renewable sources, provide strong adhesion but pose minimal skin irritation risk, making them appropriate for use in wound care products, medical tapes, and wearable devices. The growing regulatory pressure to decrease synthetic chemical and solvent-based chemical usage drives manufacturers to adopt environmentally friendly solutions, which further fuel the use of natural resins. The demand for hypoallergenic adhesive solutions is increasing due to growing awareness of patient safety and comfort. The development of new formulation technologies enhances natural resin-based adhesives, which enable their application in sophisticated medical fields and drive their fast market expansion.

“Surgery is the fastest-growing application, in terms of value.”

The medical adhesives market experiences its highest growth in surgical applications because surgical procedures are increasing worldwide, and doctors are choosing minimally invasive methods. Surgeons utilize medical adhesives for wound closure and tissue sealing, hemostasis, and internal fixation, providing operational benefits through decreased surgical duration, reduced infection risk, and improved aesthetics compared to standard sutures and staples. The increasing occurrence of chronic health conditions and traumatic injuries, together with the growing elderly population, drives higher surgical demand. The development of adhesive technologies, including bio-based sealants and high-strength cyanoacrylates, enables broader use of these materials in complex surgical operations. The surgical application segment is experiencing rapid growth as healthcare spending increases and surgical access improves, especially in developing countries.

Get a Sample Copy of This Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=41880473

“North America is projected to hold the largest share during the forecast period, in terms of value.”

North America will have the largest medical adhesives market share during the forecast period because its established healthcare system and high use of new medical technologies. The region shows increased need for medical adhesives because its population requires more surgical treatments and faces higher rates of chronic diseases, and its population base grows older. The market expands as major companies maintain a strong presence while introducing new products and investing heavily in research and development. The combination of reimbursement policies and regulatory standards protects the usage of high-quality adhesive products. The rising demand for minimally invasive surgeries, together with the demand for wearable medical devices, now drives North America to implement advanced adhesive solutions, which maintain its global market lead.

Medical Adhesives Companies

The key players in the market include Solventum (US), Henkel AG & Co. KGaA (Germany), H.B. Fuller Company (US), Scapa Healthcare (US), Johnson & Johnson (US), Permabond (UK), Chemence Medical, Inc (US), Artivion, Inc (US), Dymax (Ireland), and Bostik (France).

Solventum (US) uses its existing 3M healthcare portfolio to enhance its market position in medical adhesives through a dedicated growth strategy that expands its business in wound care, surgical solutions, and dental adhesives. The company builds its main strengths on advanced materials science, its strong brand identity, and its ability to develop new products through research. Solventum strategically manages its business portfolio by selling its purification and filtration business while investing its resources in fast-growing healthcare areas and research activities to develop better adhesive and sealant products. The organization has adopted a transformation strategy to achieve financial growth, improve profit margins, and enhance its business operations. The company that emerged after its separation from 3M now has enhanced strategic capabilities that enable it to pursue targeted acquisition and partnership opportunities.

Henkel AG & Co. KGaA (Germany) pursues a growth strategy in the medical adhesives market by developing innovative products that protect the environment and extend its Loctite medical-grade adhesive range. The main strengths of the company include its advanced adhesive technology expertise, its ability to manufacture products worldwide, and its comprehensive knowledge of medical devices and wearables. The company uses strategic acquisitions and partnerships for two purposes: to enhance its Adhesive Technologies division and to develop new healthcare products. Henkel develops vertical integration through its internal research and development programs and manufacturing facilities, which help control product quality and delivery assurance. The company develops digital solutions that help customers who need customized medical adhesives for their expanding business needs.

Inquire Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=41880473

H.B. Fuller Company (US) follows a growth strategy in the medical adhesives market through three main methods: expanding its product portfolio, developing new products, and making targeted acquisitions. The company leverages its core competencies through three main abilities: developing specialized adhesive solutions and operating its worldwide manufacturing and distribution system. The company has strengthened its healthcare position through acquisitions such as Royal Adhesives & Sealants and GEM Srl, thereby enhancing its surgical adhesives and healthcare applications capabilities. H.B. Fuller establishes vertical integration by developing its products through internal research and development and manufacturing operations, enabling it to maintain product quality while creating customized solutions. The company targets its expansion through partnerships and innovation to develop advanced medical adhesive solutions, helping it succeed in high-growth markets such as wound care and medical device assembly.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America’s best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the ‘GIVE Growth’ principle, we work with several Forbes Global 2000 B2B companies – helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: https://www.marketsandmarkets.com/Market-Reports/medical-adhesive-market-41880473.html
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/medical-adhesive-market-41880473.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Medical Adhesives Market Size, Sales Volume, Revenue, Price Analysis Report 2026-2031 | Top Key Players Analysis

Operational Technology (OT) Security Market Size, Share, Growth Analysis & Industrial Cybersecurity Trends Forecast To 2031

“Tenable (US), Microsoft (US), Forcepoint (US), Palo Alto Networks (US), Fortinet (US), Forescout (US), Seceon (US), Seclab (France), Check Point (Israel), Broadcom (US), Trellix (US), Qualys (US), Zscaler (US), BeyondTrust (US), Rapid7 (US), Sophos (UK), Tripwire (US).”
Operational Technology (OT) Security Market by Solution (SIEM, IAM, Asset Discovery & Management, Network Security), Service (Consulting & Integration, Incident Response, Managed), Deployment Mode (Cloud, On-premises) – Global Forecast to 2031.

The operational technology (OT) security market is expected to expand at a compound annual growth rate (CAGR) of 16.6% from USD 27.39 billion in 2026 to USD 58.94 billion by 2031. The integration of IT and OT settings is driving this rise by increasing the attack surface across PLC-based industrial networks, SCADA systems, and ICS. Traditionally segregated OT settings are now exposed to enterprise IT and external connectivity due to the growing use of remote operations, IIoT-enabled automation, and predictive maintenance. This creates new lateral movement channels for cyber threats. The need for OT-specific security solutions with deep protocol visibility, passive asset discovery, and real-time anomaly detection is being further accelerated by an increase in ransomware attacks that aim to interrupt operations rather than steal data.

Download PDF Brochure@ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=18524133

“Based on offering, solutions segment to lead market during forecast period”

The solutions segment is expected to hold the largest share of the OT security market during the forecast period due to increasing demand for industrial visibility, threat detection, and secure network segmentation across critical infrastructure environments. Organizations are investing heavily in OT security platforms to protect ICS, SCADA, PLCs, and connected industrial assets from ransomware, unauthorized access, and operational disruption. The growing convergence of IT and OT networks, combined with the rising deployment of IIoT devices and smart manufacturing technologies, is accelerating the adoption of advanced security solutions with capabilities such as industrial protocol inspection, anomaly detection, asset discovery, and centralized monitoring. Additionally, increasing regulatory requirements and the need to maintain uninterrupted industrial operations are driving enterprises to deploy comprehensive OT security solutions that improve cyber resilience, operational continuity, and real-time threat visibility across distributed industrial environments.

“By deployment mode, cloud segment to register higher CAGR during forecast period”

The cloud segment is expected to register a higher growth rate than the on-premises segment due to increasing adoption of cloud-connected industrial platforms, remote operational management, and centralized monitoring across distributed industrial environments. Organizations are increasingly leveraging cloud-based OT security solutions to gain scalable visibility into industrial assets, streamline threat monitoring, and support real-time analytics across geographically dispersed facilities. The growing integration of IIoT devices, edge computing, and smart manufacturing technologies is further accelerating demand for cloud-enabled security architectures capable of managing large volumes of operational data. Additionally, cloud deployment enables faster implementation, simplified updates, and centralized policy management without extensive on-premises infrastructure requirements. As enterprises continue modernizing industrial operations and adopting hybrid IT-OT environments, cloud-based OT security platforms are becoming critical for improving operational agility, threat detection, and cyber resilience across connected industrial ecosystems.

“By region, North America to account for largest market share during forecast period”

North America is expected to account for the largest share of the OT security market during the forecast period due to the strong presence of critical infrastructure industries, advanced industrial automation adoption, and significant cybersecurity investments across the US and Canada. The region has a high concentration of manufacturing plants, energy facilities, oil & gas operations, and utility networks that increasingly rely on interconnected OT and industrial control systems. Rising cyberattacks targeting critical infrastructure, including ransomware and nation-state threats against ICS and SCADA environments, are accelerating demand for advanced OT security solutions. Additionally, government-led cybersecurity initiatives, regulatory frameworks, and increasing focus on protecting national critical infrastructure are driving investments in industrial visibility, network segmentation, anomaly detection, and secure remote access technologies. The presence of major OT security vendors and the rapid adoption of Industry 4.0 technologies further strengthen market growth across North America.

Request Sample Pages@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=18524133

Unique Features in the Operational Technology (OT) Security Market

A unique characteristic of the Operational Technology (OT) Security Market is its focus on securing the convergence of information technology (IT) and operational technology environments. As industrial systems become increasingly connected to enterprise networks and cloud platforms, organizations require specialized security solutions that bridge traditional IT cybersecurity with industrial control system (ICS) protection.

OT security solutions are designed specifically to safeguard critical infrastructure sectors such as energy, utilities, manufacturing, transportation, oil & gas, and water treatment facilities. Unlike conventional cybersecurity tools, OT security platforms prioritize operational continuity, safety, and reliability while protecting industrial assets from cyber threats.

One of the most distinctive features of the market is advanced asset discovery and visibility capabilities. OT security solutions provide real-time identification of industrial devices, programmable logic controllers (PLCs), sensors, human-machine interfaces (HMIs), and industrial communication protocols, enabling organizations to maintain a complete inventory of connected assets.

Major Highlights of the Operational Technology (OT) Security Market

The Operational Technology (OT) Security Market is experiencing strong growth as cyberattacks targeting industrial control systems, critical infrastructure, and manufacturing environments become more frequent and sophisticated. Organizations are increasingly investing in OT security solutions to protect operational assets, maintain business continuity, and reduce the risk of costly disruptions.

Demand for OT security is expanding across key industries such as energy and utilities, oil & gas, manufacturing, transportation, mining, chemicals, and water treatment. These sectors rely heavily on connected operational systems, making cybersecurity a strategic priority for ensuring safe and uninterrupted operations.

The integration of IT and OT networks is a major market driver. As industrial systems become interconnected with enterprise applications and cloud platforms, organizations are implementing unified security frameworks that provide visibility and protection across both digital and operational environments.

Inquire Before Buying@ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=18524133

Top Companies in the Operational Technology (OT) Security Market

The OT Security market is led by some of the globally established players, such as Cisco (US), Tenable (US), Microsoft (US), Forcepoint (US), Palo Alto Networks (US), Fortinet (US), Forescout (US), Seceon (US), Seclab (France), Check Point (Israel), Broadcom (US), Trellix (US), Qualys (US), Zscaler (US), BeyondTrust (US), Rapid7 (US), Sophos (UK), Tripwire (US), Radiflow (Israel), Kaspersky (Russia), SentinelOne (US), Thales (France), Armis (ServiceNow) (US), Darktrace (UK), Nozomi Networks (US), Honeywell (US), Schneider Electric (France), Siemens (Germany), ABB (Switzerland), Tosibox (Finland), Claroty (US), Dragos (US), Rhebo (Germany), Shield-IoT (Israel), Cydome (Israel), Ordr (US), RunZero (US), SIGA OT Solutions (US), Waterfall Security (Israel), and OPSWAT (US). These market players have adopted various strategies, such as product launches, partnerships, contracts, expansions, and acquisitions, to strengthen their position in the OT security market. The organic and inorganic strategies have enabled market players to expand globally by providing advanced OT security solutions.

Cisco is a global technology company that delivers comprehensive OT security capabilities through its industrial cybersecurity portfolio, designed to protect critical infrastructure, manufacturing systems, and industrial control environments. In the OT security market, Cisco focuses on providing integrated visibility, segmentation, and threat detection across converged IT and OT networks using its Industrial Threat Defense architecture. The Cisco Cyber Vision solution enables deep packet inspection of industrial protocols, asset discovery, and behavioral monitoring across ICS, SCADA, and IIoT environments, helping organizations identify anomalies and unauthorized activities in real time. Cisco also strengthens OT security through secure remote access, Zero Trust segmentation, and integration with SOC platforms such as XDR and Splunk, enabling unified monitoring and response across industrial and enterprise domains. Through its network-fused security approach, Cisco helps organizations reduce blind spots in OT environments, enforce ISA/IEC 62443-aligned segmentation, and improve resilience of industrial operations against ransomware and disruptive cyberattacks.

Tenable is a cybersecurity company that provides exposure management and vulnerability assessment capabilities extended into OT environments through its unified risk and exposure platform. In the OT security market, Tenable focuses on delivering continuous asset visibility, vulnerability discovery, and risk prioritization across industrial networks, including ICS and IIoT-connected systems. Its OT security approach enables organizations to identify insecure configurations, unpatched industrial assets, and exploitable vulnerabilities that could impact critical operations. By correlating OT asset intelligence with vulnerability data, Tenable helps industrial operators reduce attack surfaces, prioritize remediation efforts, and maintain compliance with industrial cybersecurity standards. The platform supports organizations in bridging IT and OT risk visibility, enabling security teams to manage industrial cyber risk through a centralized, analytics-driven exposure management framework designed for complex and distributed operational environments.

Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email: Send Email
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: https://www.marketsandmarkets.com/Market-Reports/operational-technology-ot-security-market-18524133.html
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/operational-technology-ot-security-market-18524133.html

 

Press Release Distributed by ABNewswire.com

To view the original version on ABNewswire visit: Operational Technology (OT) Security Market Size, Share, Growth Analysis & Industrial Cybersecurity Trends Forecast To 2031